Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
07/05/2012 | WO2012091549A1 Combination of components for the prevention and treatment of frailty |
07/05/2012 | WO2012091542A1 Combination of components for the prevention and treatment of frailty |
07/05/2012 | WO2012091118A1 Therapeutic agent for ectopic pregnancy |
07/05/2012 | WO2012090939A1 Method for suppressing receptor tyrosine kinase-mediated prosurvival signaling in cancer cells |
07/05/2012 | WO2012090676A1 Novel medicinal composition and utilization of same |
07/05/2012 | WO2012089738A1 A combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease |
07/05/2012 | WO2012089053A1 Method for inhibiting myopia and use of adenylate cyclase inhibitor as drug for inhibiting myopia |
07/05/2012 | WO2012064845A3 G-csf polymer conjugates having a releasable linkage |
07/05/2012 | WO2011051948A3 Hair care compositions and materials |
07/05/2012 | US20120172525 Compositions containing inclusion complexes |
07/05/2012 | US20120172373 Method of treating cognitive impairments and schizophrenias |
07/05/2012 | CA2823306A1 Combination of components for the prevention and treatment of frailty |
07/05/2012 | CA2822528A1 A combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease |
07/04/2012 | EP2471918A1 Screening method |
07/04/2012 | EP2471916A1 Diagnosis marker, diagnosis method and therapeutic agent for amyotrophic lateral sclerosis, and animal model and cell model developing amyotrophic lateral sclerosis |
07/04/2012 | EP2471907A2 Placental stem cell populations |
07/04/2012 | EP2471906A2 Placental stem cell populations |
07/04/2012 | EP2471905A2 Placental stem cell populations |
07/04/2012 | EP2471904A2 Placental stem cell populations |
07/04/2012 | EP2471549A1 Adhesin as immunogen against Escherichia coli |
07/04/2012 | EP2471533A1 Aryl carbonyl derivatives as therapeutic agents |
07/04/2012 | EP2471360A1 Improved tissue maintenance |
07/04/2012 | EP2470651A1 Lung and esophageal cancer related gene adamts18 |
07/04/2012 | EP2470534A1 Jak inhibition blocks rna interference associated toxicities |
07/04/2012 | EP2470214A1 Method of treating frailty |
07/04/2012 | EP2470212A1 Method of treatment of philadelphia chromosome positive leukaemia |
07/04/2012 | EP2470181A1 Method of treating compulsive disorders with alpha-2b adrenergic receptor agonists |
07/04/2012 | EP2470177A1 Combination therapy for treating proliferative diseases |
07/04/2012 | EP2470170A2 Use of metformin in cancer treatment and prevention |
07/04/2012 | EP2117356B1 Anti-oxidant dietary composition containing fruits and vegetables, method for preparing the same and use of the composition |
07/04/2012 | EP2081597B1 Long-term enteral feed for maintenance |
07/04/2012 | EP2062887B1 Aminopyridine derivative having aurora a-selective inhibitory activity |
07/04/2012 | EP1942938B1 Use of oligouronates for treating mucus hyperviscosity |
07/04/2012 | EP1879654B1 Pharmaceutical combination comprising an antifungal agent and an active substance selected especially from eugenol and carvacrol |
07/04/2012 | EP1744781B1 Treatment of infectious diseases |
07/04/2012 | EP1487805B1 Pyrimidine derivatives |
07/04/2012 | CN1845911B Condensed ring compound and use thereof |
07/04/2012 | CN1338939B Compositions for the treatment of male erectile dysfunction |
07/04/2012 | CN102548579A Dosage regimen of an s1p receptor modulator |
07/04/2012 | CN102548551A Derivatives of N-hydroxybenzamide for treating HIV infections |
07/04/2012 | CN102548541A Floating microgranules |
07/04/2012 | CN102548536A Olopatadine compositions and uses thereof |
07/04/2012 | CN102533972A IL1RL-1 as a cardiovascular disease marker and therapeutic target |
07/04/2012 | CN102533868A Application of Lactobacillus casei LC2W in preparation of Alpha-glycosidase inhibitor |
07/04/2012 | CN102533569A Separation screening method of paper mulberry endophytic fungi and application thereof |
07/04/2012 | CN102532135A Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors |
07/04/2012 | CN102532134A Azaindoles useful as inhibitors of janus kinases |
07/04/2012 | CN102532133A Azaindoles useful as inhibitors of janus kinases |
07/04/2012 | CN102526771A Invisible nano-liposome injection for encapsulating USPIO (Ultra-small Super Paramagnetic Iron Oxide) and preparation method and application thereof |
07/04/2012 | CN102526762A Application of ALC1 to preparation of leukaemia drug resistance reversing agent and as drug-resistant leukaemia diagnosing reagent |
07/04/2012 | CN102526740A Novel high-efficiency antiemetic medicinal composition |
07/04/2012 | CN102526739A Medicament composition for treating diabetes and application of medicament composition |
07/04/2012 | CN102526738A Compound ophthalmic preparation and preparation method as well as application thereof |
07/04/2012 | CN102526737A DPP IV inhibitor formulations |
07/04/2012 | CN102526736A Treatment of inflammatory diseases |
07/04/2012 | CN102526735A Pharmaceutical compositions and method of treating atherosclerosis, dyslipidemias and related conditions |
07/04/2012 | CN102526734A Medicine composition for treating age-related hearing loss (ARHL) and application thereof |
07/04/2012 | CN102526733A Composition for preventing onset and/or recurrence of cardiovascular events |
07/04/2012 | CN102526732A Application of targeted medicine adjusting histone acetylation level in aspect of preparing medicine for preventing or treating autoimmune disease |
07/04/2012 | CN102526731A Pharmaceutical composition containing arctigenin |
07/04/2012 | CN102526706A Remedy and therapeutic method for periodontal diseases and pulpal diseases |
07/04/2012 | CN102526079A 治疗脱髓鞘疾病的鞘氨醇-1-磷酸受体激动剂 Treatment of demyelinating diseases of the sphingosine-1-phosphate receptor agonist, |
07/04/2012 | CN102526045A Methods of increasing endogenous erythropoietin EPO |
07/04/2012 | CN102526044A Methods of increasing endogenous erythropoietin EPO |
07/04/2012 | CN102526029A Pharmaceutical combination comprising atorvastatin derivatives |
07/04/2012 | CN102526002A Autodestructive transdermal therapeutic system |
07/04/2012 | CN102525972A Calcium-ion antagonist orally disintegrating tablet and preparation method thereof |
07/04/2012 | CN102525971A Gastrointestinal motility promoting medicinal oral disintegrating tablets and preparation method thereof |
07/04/2012 | CN102525884A Thermosensitive in-situ gel preparation for vaginal administration |
07/04/2012 | CN102525720A Condom and manufacture method thereof |
07/04/2012 | CN102049047B Drug combination |
07/04/2012 | CN102008730B Transdermal medicine composition and transdermal medicine kit |
07/04/2012 | CN101780092B Compounds and methods for delivery of prostacyclin analogs |
07/04/2012 | CN101757621B Cyclodextrin inclusion drug composition for ocular inflammation resistance |
07/04/2012 | CN101491536B Therapeutically useful synthetic oligonucleotides |
07/03/2012 | US8212057 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
07/03/2012 | US8211887 Topical preparation and method for transdermal delivery and localization of therapeutic agents |
07/03/2012 | US8211876 Compositions for treatment of inflammatory diseases |
07/03/2012 | US8211666 Sperm-specific cation channel, CATSPER1, and uses therefor |
07/03/2012 | US8211458 Methods of performing medical procedures that promote bone growth, methods of making compositions that promote bone growth, and apparatus for use in such methods |
07/03/2012 | US8211435 Calf biologic anti-scour supplement (CBAS) |
07/03/2012 | US8211421 Mutant having uracil phosphoribosyl transferase activity |
07/03/2012 | US8211420 Interleukin-21 variants with altered binding to the IL-21 receptor |
07/03/2012 | CA2694227C Compositions and methods for treating or controlling anterior-segment inflammation |
07/03/2012 | CA2661960C Noninvasive measurements of chemical substances |
07/03/2012 | CA2567023C Compositions and methods for bone formation and remodeling |
07/03/2012 | CA2522248C Methods of treatment using specific binding agents of human angiopoietin-2 |
07/03/2012 | CA2517135C 1-n-arylpyrazole derivatives in prevention of arthropod-borne and mosquito-borne diseases |
07/03/2012 | CA2500713C Photokinetic delivery of biologically active substances using pulsed incoherent light |
07/03/2012 | CA2445577C Subcellular targeting of therapeutic proteins |
07/03/2012 | CA2409647C Methods of treating androgen deficiency in men using selective antiestrogens |
07/03/2012 | CA2388818C C-aryl glucoside sglt2 inhibitors and method |
06/28/2012 | WO2012087377A1 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
06/28/2012 | WO2012086809A1 Accurate and highly sensitive method for measuring activity of human fgf19 and agent for regulating activity of human fgf19 |
06/28/2012 | WO2012085954A1 Combination comprising d-apartic acid and l-arginine or salts thereof for the improvement of cognitive activities and memory in dementia such as dementia senile and alzheimer's disease |
06/28/2012 | WO2012085683A1 The use of spinosyns and spinosyn compositions as local anesthetics and as antiarrhythmic agents |
06/28/2012 | WO2012085674A1 Single nucleotide polymorphisms and genes associated with t2d-related complications |
06/28/2012 | WO2012085068A1 Kit-in-parts for cleaning and treating ears of companion animals |
06/28/2012 | WO2012084869A1 Modulators of trpa1 for the treatment of rosacea |
06/28/2012 | US20120165359 Opioid Agonist/Antagonist Combinations |